Paracetamol poisoning

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:464458T88.7
Who is this for?
Show terms as
2FDA treatments2Active trials21Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Paracetamol poisoning, also known as acetaminophen overdose or acetaminophen toxicity, occurs when a person takes too much paracetamol (called acetaminophen in the United States and Canada). Paracetamol is one of the most commonly used pain relievers and fever reducers worldwide, found in hundreds of over-the-counter and prescription medications. While safe at recommended doses, taking too much can cause severe and potentially life-threatening liver damage. When the body processes normal amounts of paracetamol, the liver breaks it down safely. However, when too much is taken, the liver cannot keep up, and a toxic byproduct called NAPQI builds up. This toxic substance directly damages liver cells and can lead to acute liver failure if not treated promptly. Poisoning can happen from a single large overdose or from repeatedly taking slightly too much over several days (called a staggered overdose). Early symptoms may be mild or absent, which makes this condition particularly dangerous. Within the first 24 hours, a person may feel nauseous, vomit, or simply feel unwell. Over the next few days, signs of liver damage appear, including abdominal pain in the upper right side, yellowing of the skin and eyes (jaundice), and confusion. The main treatment is a medication called N-acetylcysteine (NAC), which works as an antidote and is most effective when given within 8 hours of the overdose. With prompt treatment, most people recover fully, but delayed treatment can lead to liver failure requiring a liver transplant or can be fatal.

Also known as:

Key symptoms:

Nausea and vomitingLoss of appetiteAbdominal pain, especially in the upper right sideYellowing of the skin and eyes (jaundice)Dark-colored urinePale or clay-colored stoolsExcessive sweatingFeeling generally unwell or tiredConfusion or difficulty thinking clearlyUnusual bleeding or bruisingSwelling in the abdomen from fluid buildupLow blood sugar symptoms such as shakinessKidney problems including reduced urine outputIn severe cases, loss of consciousness or coma

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Apr 2026Evaluation of Differences Between the Standered NAC Regimen Protocol and the SNAP Regimen Protocol in the Treatment of Paracetamol Toxicity for Cases Presented Early and Late to Assiut University Hospitals in Terms of Safety and Efficiecy.

Assiut University — NA

TrialNOT YET RECRUITING
Sep 2020Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.

University Hospital, Ghent

TrialRECRUITING
Aug 2020Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

The First Affiliated Hospital with Nanjing Medical University

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

Acetylcysteine

ACETYLCYSTEINE· Hospira, Inc.

indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen

Cetylev

acetylcysteine effervescent tablets for oral solution· Arbor Pharmaceuticals, Inc.

Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion

Clinical Trials

2 recruitingView all trials with filters →
Other2 trials
Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study
Actively Recruiting
PI: Jingsong Zhang, professor (The First Affiliated Hospital with Nanjing Medical) · Sites: Nanjing, Jiangsu · Age: 1499 yrs
Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.
Actively Recruiting
PI: Luc De Baerdemaeker, Md,PhD (University Hospital, Ghent) · Sites: Ghent, Oost-Vlaanderen · Age: 1870 yrs

Specialists

21 foundView all specialists →
RM
Robert H Squires, M.D.
JACKSONVILLE, FL
Specialist
PI on 1 active trial
HT
Harry K Thanacoody
Specialist
PI on 1 active trial
JD
James Dear
Specialist
PI on 1 active trial1 Paracetamol poisoning publication
JC
Jamie G Cooper
Specialist
PI on 1 active trial49 Paracetamol poisoning publications
AG
Alasdair J Gray
Specialist
PI on 1 active trial12 Paracetamol poisoning publications
HM
Henry Farrar, MD
LITTLE ROCK, AR
Specialist
PI on 1 active trial
RM
Robert H Squires, MD
JACKSONVILLE, FL
Specialist
PI on 2 active trials
WM
William M Lee, MD
Specialist
PI on 3 active trials1 Paracetamol poisoning publication
MJ
Muhammad Irfan Jamil
Specialist
PI on 3 active trials13 Paracetamol poisoning publications
MM
Michael Ganetsky, MD
BOSTON, MA
Specialist
PI on 1 active trial
HG
Henning Grønbæk
Specialist
PI on 1 active trial4 Paracetamol poisoning publications
LM
Luc De Baerdemaeker, Md,PhD
Specialist
PI on 1 active trial
MP
Martha Blackford, PharmD
WASHINGTON, DC
Specialist
PI on 3 active trials
EB
Euan A Sandilands, MRCP BSc
Specialist
PI on 1 active trial
LM
Laura James, M.D.
Specialist
PI on 1 active trial
SM
Steven Salhanick, MD
BOSTON, MA
Specialist
PI on 1 active trial
UG
Umut Gülaçtı
Specialist
PI on 1 active trial2 Paracetamol poisoning publications
KM
Kennon Heard, MD
AURORA, CO
Specialist
PI on 4 active trials
TD
TeYu Mr Lin, Dr.
Specialist
PI on 1 active trial
RD
Richard Dart
AURORA, CO
Specialist
PI on 1 active trial
JZ
Jingsong Zhang
TAMPA, FL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Paracetamol poisoning.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Paracetamol poisoningForum →

No community posts yet. Be the first to share your experience with Paracetamol poisoning.

Start the conversation →

Latest news about Paracetamol poisoning

Disease timeline:

New recruiting trial: Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

A new clinical trial is recruiting patients for Paracetamol poisoning

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is the liver damage, and what do my blood test results mean?,Was treatment started early enough to prevent long-term liver problems?,Will I need any follow-up blood tests to check my liver function, and for how long?,Are there any medications or supplements I should avoid while my liver recovers?,Is it safe for me to ever take paracetamol again in the future?,Should I be referred for mental health support or counseling?,What warning signs should I watch for that would mean I need to come back to the hospital?

Common questions about Paracetamol poisoning

What is Paracetamol poisoning?

Paracetamol poisoning, also known as acetaminophen overdose or acetaminophen toxicity, occurs when a person takes too much paracetamol (called acetaminophen in the United States and Canada). Paracetamol is one of the most commonly used pain relievers and fever reducers worldwide, found in hundreds of over-the-counter and prescription medications. While safe at recommended doses, taking too much can cause severe and potentially life-threatening liver damage. When the body processes normal amounts of paracetamol, the liver breaks it down safely. However, when too much is taken, the liver cannot

How is Paracetamol poisoning inherited?

Paracetamol poisoning follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Paracetamol poisoning?

Yes — 2 recruiting clinical trials are currently listed for Paracetamol poisoning on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Paracetamol poisoning?

21 specialists and care centers treating Paracetamol poisoning are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.